ArticleCancers2022

Anti-Programmed Cell Death-1 Antibody and Dasatinib Combination Therapy Exhibits Efficacy in Metastatic Colorectal Cancer Mouse Models.

Hiroki Kadota et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.